For: | Cui J, Dong BW, Liang P, Yu XL, Yu DJ. Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma. World J Gastroenterol 2005; 11(20): 3027-3033 [PMID: 15918184 DOI: 10.3748/wjg.v11.i20.3027] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3027.htm |
Number | Citing Articles |
1 |
Mathieu Boissan, Marie-Lise Lacombe. Nm23/NDP kinases in hepatocellular carcinoma. Journal of Bioenergetics and Biomembranes 2006; 38(3-4): 169 doi: 10.1007/s10863-006-9031-4
|
2 |
Zhengbin Zhang, Dylan Harris, Virendra N. Pandey. The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C Virus. Journal of Virology 2008; 82(12): 5761 doi: 10.1128/JVI.00064-08
|
3 |
Zhao-Hui Sun, Wen-Li Ma, Bao Zhang, Yi-Fei Peng, Wen-Ling Zheng. Application of restriction display PCR technique in the preparation of cDNA microarray probes. World Journal of Gastroenterology 2005; 11(48): 7579-7584 doi: 10.3748/wjg.v11.i48.7579
|
4 |
Rajeev Kaul, Masanao Murakami, Pankaj Kumar, Erle S. Robertson. Cancer Genome and Tumor Microenvironment. 2010; : 233 doi: 10.1007/978-1-4419-0711-0_11
|
5 |
A. EL‐BASSIOUNI, M. NOSSEIR, M. ZOHEIRY, E. EL‐AHWANY, A. GHALI, N. EL‐BASSIOUNI. Immunohistochemical expression of CD95 (Fas), c‐myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. APMIS 2006; 114(6): 420 doi: 10.1111/j.1600-0463.2006.apm_323.x
|
6 |
Christopher D. Mann, Christopher P. Neal, Giuseppe Garcea, Margaret M. Manson, Ashley R. Dennison, David P. Berry. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. European Journal of Cancer 2007; 43(6): 979 doi: 10.1016/j.ejca.2007.01.004
|
7 |
Hanan H. Fouad, Ahmed B. Demery, Hussein M. Yehia, Reda M. El-Badawy. Molecular markers as a prognostic system for hepatocellular carcinoma. Journal of Advanced Research 2011; 2(4): 333 doi: 10.1016/j.jare.2011.02.006
|
8 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
9 |
Choon-Yee Tan, Christina L Chang. NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma. Laboratory Investigation 2018; 98(2): 219 doi: 10.1038/labinvest.2017.105
|
10 |
|
11 |
|
12 |
Godfrey Grech, Xianquan Zhan, Byong Chul Yoo, Rostyslav Bubnov, Suzanne Hagan, Romano Danesi, Giorgio Vittadini, Dominic M Desiderio. EPMA position paper in cancer: current overview and future perspectives. EPMA Journal 2015; 6(1) doi: 10.1186/s13167-015-0030-6
|
13 |
Chengkun Yang, Chuangye Han, Xiangkun Wang, Xiwen Liao, Xiaoguang Liu, Wei Qin, Long Yu, Guangzhi Zhu, Hao Su, Sicong Lu, Zhiwei Chen, Tingdong Yu, Zhen Liu, Ketuan Huang, Zhengtao Liu, Yu Liang, Jianlu Huang, Tao Peng. Clinical Implication and the Hereditary Factors of NM23 in Hepatocellular Carcinoma Based on Bioinformatics Analysis and Genome–Wide Association Study. Journal of Oncology 2018; 2018: 1 doi: 10.1155/2018/6594169
|
14 |
Lohit Khera, Catherine Paul, Rajeev Kaul. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1. Virology 2017; 506: 110 doi: 10.1016/j.virol.2017.03.014
|
15 |
Ji-Dong Chen, Yan-Qun Xiong, Ke Dong, Jun Luo, Lin-Xian Yue, Qin Chen. Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy. Asian Pacific Journal of Cancer Prevention 2014; 15(11): 4545 doi: 10.7314/APJCP.2014.15.11.4545
|
16 |
Mohammed Asmal, Michael Seaman, Wenyu Lin, Raymond T Chung, Norman L Letvin, Ralf Geiben-Lynn. Inhibition of HCV by the serpin antithrombin III. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-226
|